Health & Wellness
Liberty HealthShare announced March 4 that applications are now open for the third round of its Sharing Hearts Fund for Pediatric Wellness, a charitable program the Canton, Ohio-based healthcare sharing ministry created in 2025 to help Stark County families in need with the cost of routine children’s medical care. Up to $50,000 is available in this grant cycle. Applications are being accepted through May 15.
The fund addresses a specific gap in pediatric healthcare access, not treatment of illness or injury, but the routine wellness visits that families frequently postpone when money is tight. Grant eligible services include physical exams, dental exams and teeth cleaning, vision exams and eyeglasses, and hearing tests.
Two Rounds, Nearly $25,000 Awarded So Far
The Sharing Hearts Fund has distributed almost $25,000 to 10 Stark County families since it launched in early 2025. The first grant cycle, completed in April of that year, awarded approximately $17,000. A second round, completed in December 2025, added approximately $10,000 more. The third round, now open, more than doubles the total funding made available in any prior cycle.
National public health data cited in the press release underscores why the fund was created. About one-quarter of families have missed or delayed well-child visits in part due to cost. Research also shows that out-of-pocket expenses correlate with lower use of preventive services — meaning children from lower-income households are less likely to receive the routine screenings that catch problems early.
A Ministry Investing in Its Hometown
Liberty HealthShare, founded in 1995, is headquartered in Canton, Ohio, which sits in Stark County. Chief Executive Officer Dorsey Morrow described the fund as an extension of the organization’s identity as a community institution, not just a national ministry.
“Liberty HealthShare is blessed to be able to support children with important medical needs that they otherwise would have to forego due to cost,” Morrow said in the announcement.
...When breast cancer becomes metastatic, treatment usually turns into an ongoing process rather than a single choice. Plans shift over time. Therapies change as the disease evolves, as previous responses become clearer, and as personal priorities move. In recent years, personalized immunotherapy has entered these discussions more often — not as a replacement for standard care, but as an area some patients want to understand better.
Among the approaches that occasionally come up is dendritic cell therapy. This article examines the method’s foundation, how it may fit into treatment planning for metastatic breast cancer, and what patients should keep in mind when considering centers in Germany. It is an educational overview only and should not be used as medical advice.
What “Personalized Immunotherapy” Means in Metastatic Breast Cancer
When doctors talk about personalized treatment in metastatic breast cancer, they usually mean looking closely at what makes each case different. Tumor biology, hormone and HER2 status, relevant biomarkers, and features of the tumor microenvironment all influence which options make sense at a given time.
Previous treatments, overall health, and day‑to‑day well-being also shape what is realistic. Immunotherapy is part of the discussion for some patients, but it is not automatically suitable for everyone.
Unlike treatments that work the same way for most people, immunotherapy depends heavily on how the immune system and the cancer interact. Some tumors show characteristics that make immune‑based approaches more relevant, while others do not. A pathology review or re‑review may be needed to confirm key details before decisions are made.
That is why decisions are usually made within a multidisciplinary tumor board, where oncologists, radiologists, and pathologists review the full picture together. Their role is to help patients understand what is realistic, what is still being studied, and where immunotherapy may or may not fit into a broader care plan.
...
